[HTML][HTML] Involvement of heparanase in atherosclerosis and other vessel wall pathologies

I Vlodavsky, M Blich, JP Li, RD Sanderson, N Ilan - Matrix Biology, 2013 - Elsevier
I Vlodavsky, M Blich, JP Li, RD Sanderson, N Ilan
Matrix Biology, 2013Elsevier
Heparanase, the sole mammalian endoglycosidase degrading heparan sulfate, is causally
involved in cancer metastasis, angiogenesis, inflammation and kidney dysfunction. Despite
the wide occurrence and impact of heparan sulfate proteoglycans in vascular biology, the
significance of heparanase in vessel wall disorders is underestimated. Blood vessels are
highly active structures whose morphology rapidly adapts to maintain vascular function
under altered systemic and local conditions. In some pathologies (restenosis, thrombosis …
Heparanase, the sole mammalian endoglycosidase degrading heparan sulfate, is causally involved in cancer metastasis, angiogenesis, inflammation and kidney dysfunction. Despite the wide occurrence and impact of heparan sulfate proteoglycans in vascular biology, the significance of heparanase in vessel wall disorders is underestimated. Blood vessels are highly active structures whose morphology rapidly adapts to maintain vascular function under altered systemic and local conditions. In some pathologies (restenosis, thrombosis, atherosclerosis) this normally beneficial adaptation may be detrimental to overall function. Enzymatic dependent and independent effects of heparanase on arterial structure mechanics and repair closely regulate arterial compliance and neointimal proliferation following endovascular stenting. Additionally, heparanase promotes thrombosis after vascular injury and contributes to a pro-coagulant state in human carotid atherosclerosis. Importantly, heparanase is closely associated with development and progression of atherosclerotic plaques, including stable to unstable plaque transition. Consequently, heparanase levels are markedly increased in the plasma of patients with acute myocardial infarction. Noteworthy, heparanase activates macrophages, resulting in marked induction of cytokine expression associated with plaque progression towards vulnerability. Together, heparanase emerges as a regulator of vulnerable lesion development and potential target for therapeutic intervention in atherosclerosis and related vessel wall complications.
Elsevier